PMV Pharmaceuticals Inc. (PMVP)
NASDAQ: PMVP
· Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.49
-1.00%
After-hours: Aug 15, 2025, 05:54 PM EDT
PMV Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 32K | n/a | n/a | n/a | 372K | 362K | 359K | 358K | 369K | 82K | 160K | 144K | 179K | 167K | 407K | 410K | 71K | 79K |
Gross Profit | -32K | n/a | n/a | n/a | -372K | -362K | 1.26M | -358K | -369K | -82K | -160K | -144K | -179K | -167K | -407K | -410K | -71K | -79K |
Operating Income | -22.88M | -21.56M | -25.17M | -21.89M | -20.17M | -18.22M | -18.9M | -19.63M | -20.12M | -21.48M | -21.16M | -19.38M | -17.89M | -18.62M | -18.47M | -15.1M | -13.05M | -11.67M |
Interest Income | 1.69M | n/a | 2.29M | 2.62M | 2.8M | 2.95M | 3.17M | 2.98M | 2.7M | 2.33M | 1.8M | 1.12M | 604K | 229K | 106K | 102K | 113K | 128K |
Pretax Income | -21.2M | -19.63M | -23M | -19.15M | -17.39M | -15.27M | -15.76M | -16.64M | -17.43M | -19.13M | -19.34M | -18.24M | -17.31M | -18.43M | -18.36M | -14.99M | -12.87M | -11.6M |
Net Income | -21.21M | -17.44M | -23M | -19.23M | -1.21M | -15.27M | -15.76M | -16.64M | -17.44M | -16.78M | -19.33M | -18.23M | -17.31M | -18.43M | -18.36M | -15.01M | -12.87M | -11.6M |
Selling & General & Admin | 4.48M | 4.12M | 11.4M | 4.94M | 5.54M | 5.04M | 5.52M | 6.04M | 6.28M | 6.41M | 6.14M | 5.71M | 6.42M | 6.78M | 6.3M | 5.93M | 5.39M | 4.17M |
Research & Development | 18.37M | 17.44M | 13.77M | 16.95M | 14.26M | 12.82M | 13.02M | 13.59M | 13.84M | 15.07M | 15.03M | 13.67M | 11.46M | 11.84M | 12.17M | 9.16M | 7.66M | 7.5M |
Other Expenses | n/a | n/a | n/a | n/a | -17K | -1K | -21K | 4K | -6K | 27K | 20K | 13K | -31K | -41K | 7K | 3K | 63K | -52K |
Operating Expenses | 22.85M | 21.56M | 25.17M | 21.89M | 19.8M | 17.86M | 18.54M | 19.63M | 20.12M | 21.48M | 21.16M | 19.38M | 17.89M | 18.62M | 18.47M | 15.1M | 13.05M | 11.67M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.88M | 21.56M | 25.17M | 21.89M | 20.17M | 18.22M | 18.9M | 19.63M | 20.12M | 21.48M | 21.16M | 19.38M | 17.89M | 18.62M | 18.47M | 15.1M | 13.05M | 11.67M |
Income Tax Expense | 5K | -2.2M | n/a | 74K | -16.17M | n/a | -1K | n/a | 4K | -2.35M | -18K | -9K | -2K | 2K | 23K | 19K | -113K | 4K |
Shares Outstanding (Basic) | 52.01M | 51.95M | 51.57M | 51.57M | 51.48M | 51.45M | 51.45M | 49.05M | 45.81M | 45.77M | 45.7M | 45.62M | 45.57M | 45.47M | 45.3M | 45.3M | 45.07M | 44.79M |
Shares Outstanding (Diluted) | 52.01M | 51.95M | 51.57M | 51.57M | 51.48M | 51.45M | 51.45M | 49.05M | 45.81M | 45.77M | 45.7M | 45.62M | 45.57M | 45.47M | 45.3M | 45.3M | 45.07M | 44.79M |
EPS (Basic) | -0.41 | -0.34 | 0.37 | -0.37 | -0.02 | -0.3 | -0.31 | -0.34 | -0.38 | -0.42 | -0.42 | -0.4 | -0.38 | -0.41 | -0.41 | -0.33 | -0.29 | -0.26 |
EPS (Diluted) | -0.41 | -0.34 | 0.37 | -0.37 | -0.02 | -0.3 | -0.31 | -0.34 | -0.38 | -0.42 | -0.42 | -0.4 | -0.38 | -0.41 | -0.41 | -0.33 | -0.29 | -0.26 |
EBITDA | -21.17M | -21.56M | -25.13M | -21.52M | -19.8M | -17.18M | -18.54M | -19.27M | -19.75M | -21.31M | -21.09M | -19.3M | -17.8M | -18.54M | -18.39M | -15.02M | -12.98M | -11.6M |
EBIT | -21.2M | -21.56M | -25.17M | -21.89M | -20.17M | -18.22M | -18.9M | -19.63M | -20.12M | -21.48M | -21.16M | -19.38M | -17.89M | -18.62M | -18.47M | -15.1M | -13.05M | -11.67M |
Depreciation & Amortization | 32K | 37K | 39K | 371K | 372K | 362K | 359K | 358K | 369K | 82K | 160K | 144K | 179K | 167K | 407K | 410K | 71K | 79K |